17-N-Allylamino-17-demethoxygeldanamycin: Cancer, Leukemia, Tumor, Hsp90, Clinical trial, Pharmaceutical drug, Antineoplastic

Prices from
127.10

Featured

COMPARE ALL WEBSHOPS (2)

Description

17-N-Allylamino-17-demethoxygeldanamycin: Cancer, Leukemia, Tumor, Hsp90, Clinical trial, Pharmaceutical drug, Antineoplastic

Description Description
Product Specifications Product specifications
Related results Related results
Next
Previous

Compare webshops (2)

Shop
Price
Amazon Logo
€ 127.10
To Shop
Amazon Marketplace Logo
€ 127.10
To Shop
Description (0)

17-N-Allylamino-17-demethoxygeldanamycin: Cancer, Leukemia, Tumor, Hsp90, Clinical trial, Pharmaceutical drug, Antineoplastic

Product specifications

Brand OmniScriptum
EAN
  • 9786132919274

OmniScriptum

Approved Drug: Food and Drug Administration, Pharmaceutical drug, New Application, Clinical trial, discovery

€ 127.10
Compare 2 stores 2 stores

Independently Published

Cancer Immunotherapy: From Tumor Biology to Clinical Practice

€ 59.85
Compare 2 stores 2 stores

Springer

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17

€ 140.70
Compare 2 stores 2 stores

OmniScriptum

Tumor Lysis Syndrome: Metabolism, Lymphoma, Leukemia

€ 145.79
Compare 2 stores 2 stores
Featured Choice
€ 127.10
To Shop